In ovarian cancer cell lines, the WEE1 inhibitor AZD1775 modulates the immune response by inducing expression of endogenous retroviral elements (ERVs), which produces double-stranded RNA (dsRNA), activating IFN-mediated anti-tumor signaling and upregulating PD-L1. Here, CD274 is linked to ovarian cancer.